Nuvalent, Inc. Stock Performance
as on October 23, 2025 at 1:29 am IST
Day's Low
Day's High
$90.72$97.94
0.08%
Downside
7.88%
Upside
52 Week's Low
52 Week's High
$55.54$99.9438.83%
Downside
10.08%
Upside
Nuvalent, Inc. share price movements today
- Previous Close
- $97.18
- Open
- $96.54
- Volume
- 584.9K
- Day's Low - High
- $90.72 - $97.94
- 52 Week Low - High
- $55.54 - $99.94
Nuvalent, Inc. Historical Returns
- 1 Month Return
- + 12.09 %
- 3 Month Return
- + 12.92 %
- 1 Year Return
- -3.02 %
- 3 Year Return
- + 356.91 %
- 5 Year Return
- 0 %
Nuvalent, Inc. Stock Fundamentals & Key Indicators
Check Nuvalent, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.7B
EPS (TTM)
-5.081
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
51375000.00%
Nuvalent, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Nuvalent, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $6.7B | NA | NA | 0.00% | |
| BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
| BUY | $61.3B | 0.85% | 14.6 | 31.37% |
Stock Returns calculator for Nuvalent, Inc. Stock including INR - Dollar returns
The Nuvalent, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nuvalent, Inc. investment value today
Current value as on today
₹1,01,441
Returns
₹1,441
(+1.44%)
Returns from Nuvalent, Inc. Stock
Dollar Returns*
₹4,557 (+4.56%)
Analyst Recommendation on Nuvalent, Inc. Stock
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Nuvalent, Inc.. Average target price of $117.53
Nuvalent, Inc. Share Price Target
Get share price movements and forecasts by analysts on Nuvalent, Inc..
What analysts predicted
22.75%UPSIDE
Target Price
$117.53
Current Price
$90.79
Analyzed by
16 Analysts
Target
$117.53
Nuvalent, Inc. target price $117.53, a slight upside of 22.75% compared to current price of $90.79. According to 16 analysts rating.
Nuvalent, Inc. Stock’s Investor Sentiment and Interest
Search interest for Nuvalent, Inc. Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:133% versus previous 30 day period
Nuvalent, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Nuvalent, Inc. Annual Profit & Loss
All numbers in Millions USD
Nuvalent, Inc. Quarterly Cash Flow
All numbers in Millions USD
Nuvalent, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Nuvalent, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, NUVL has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, NUVL stock has moved up by 7.5%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.7% return, outperforming this stock by 57.0%
About Nuvalent, Inc.
| Organisation | Nuvalent, Inc. |
| Headquarters | One Broadway, Cambridge, MA, United States, 02142 |
| Industry | Services |
| CEO | Dr. James R. Porter Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Nuvalent, Inc.
Name | Title |
|---|---|
Ms. Darlene Noci | Chief Development Officer |
Dr. Benjamin Lane Ph.D. | Senior Vice President of Technical Operations |
Dr. Henry Pelish Ph.D. | Chief Scientific Officer |
Dr. James R. Porter Ph.D. | CEO, President & Director |
Ms. Alexandra Balcom CPA, M.B.A. | CFO & Treasurer |
Ms. Deborah Ann Miller J.D., Ph.D. | Chief Legal Officer & Secretary |
Mr. John Soglia Ph.D. | Senior Vice President of Translational Development |
Prof. Matthew D. Shair Ph.D. | Founder, Head of Scientific Advisory Board & Director |
Dr. Christopher D. Turner M.D. | Chief Medical Officer |
Mr. Matthew Metivier M.B.A. | Senior Vice President of Human Resources |
FAQs
What is Nuvalent, Inc. share price today?
Nuvalent, Inc. share price today is $90.79 as on at the close of the market. Nuvalent, Inc. share today touched a day high of $97.94 and a low of $90.72.
What is the 52 week high and 52 week low for Nuvalent, Inc. share?
Nuvalent, Inc. share touched a 52 week high of $99.94 on and a 52 week low of $55.54 on . Nuvalent, Inc. stock price today i.e. is closed at $90.79,which is 9.16% down from its 52 week high and 63.48% up from its 52 week low.
What is Nuvalent, Inc.'s market capitalisation today?
Nuvalent, Inc. market capitalisation is $0.01T as on .
How to invest in Nuvalent, Inc. Stock (NUVL) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Nuvalent, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvalent, Inc. Shares that will get you 0.0165 shares as per Nuvalent, Inc. share price of $90.79 per share as on October 23, 2025 at 1:29 am IST.
What is the minimum amount required to buy Nuvalent, Inc. Stock (NUVL) from India?
Indian investors can start investing in Nuvalent, Inc. (NUVL) shares with as little as ₹87.755 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Nuvalent, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nuvalent, Inc. share’s latest price of $90.79 as on October 23, 2025 at 1:29 am IST, you will get 0.1101 shares of Nuvalent, Inc.. Learn more about
fractional shares .